Seasonal Allergy Shot: SCIT Regimen, Evidence & What It Actually Is
A seasonal allergy shot is subcutaneous immunotherapy (SCIT) targeting the specific tree, grass, and weed pollens responsible for spring–summer–fall allergic rhinitis — not a separate seasonal product. Cochrane Calderón 2007 (51 RCTs, 2,871 patients) found symptom SMD −0.73 and medication SMD −0.57. The regimen spans 3–5 years with Year 1 requiring approximately 39 in-clinic visits per Cox 2011 PP3.
7 peer-reviewed sources
A seasonal allergy shot is a multi-year SCIT course targeting specific pollens identified by IgE testing — not a single yearly injection. The Cochrane meta-analysis found a symptom SMD of −0.73 versus placebo across 51 RCTs.
The essentials
A seasonal allergy shot is subcutaneous immunotherapy (SCIT) tailored to the tree, grass, and weed pollens that drive a given patient's spring–summer–fall allergic rhinitis — not a distinct product formulation labeled "seasonal" versus "year-round." The extract menu is identical to perennial SCIT; what changes is the weighting: a Northeast patient's vial may emphasize oak, birch, timothy grass, and short ragweed, while a Southwest patient's vial targets mountain cedar, Bermuda grass, and ragweed. The SCIT protocol itself is allergen-agnostic.
Regional pollen patterns anchor extract selection. Northeast: spring oak, birch, and hickory; late spring–summer timothy grass, orchard grass, and Kentucky bluegrass; late summer–fall short ragweed (Ambrosia artemisiifolia) east of the Rockies. Southwest: mountain cedar (Juniperus ashei) peaking December–February in Texas and Oklahoma; Bermuda grass year-round; ragweed in fall. Midwest: ragweed-dominant fall season. Pacific Northwest: alder and birch heavy in early spring. A board-certified allergist uses IgE testing results alongside regional pollen calendars to select which allergens belong in the vial.
Curex pairs at-home IgE testing with board-certified allergist review to map which specific pollens — tree, grass, ragweed, or regional weeds — actually drive a patient's seasonal symptoms, so the immunotherapy plan targets the biology, not the calendar.
The evidence base for seasonal SCIT is the deepest in the immunotherapy literature. Cochrane Calderón 2007 synthesized 51 RCTs across 2,871 patients and found a symptom standardized mean difference (SMD) of −0.73 (95% CI −0.97 to −0.50) and a medication-use SMD of −0.57 (95% CI −0.82 to −0.33). Walker 2001 JACI documented ~49% symptom-score reduction and ~80% medication-score reduction versus placebo in a grass SCIT RCT (P=.007). Durham 1999 NEJM showed grass SCIT delivered three years of sustained clinical benefit after a 3–4 year course — the foundational disease-modification finding. The pediatric PAT study (Möller 2002, Jacobsen 2007) documented a 10-year halving of asthma incidence in children who completed pollen SCIT.
A critical disambiguation: the "yearly seasonal shot" some patients have received — a single intramuscular injection of triamcinolone acetonide (Kenalog-40) or methylprednisolone acetate (Depo-Medrol) — is a depot corticosteroid, not immunotherapy. The Depo-Medrol FDA label specifies symptom relief lasting "several days to three weeks." The AAAAI/ACAAI rhinitis Practice Parameter discourages single parenteral steroid administration for routine seasonal AR and contraindicates recurrent use due to hypothalamic-pituitary-adrenal (HPA) axis suppression. SCIT delivers disease modification; depot steroids suppress symptoms temporarily.
How allergy shots retrain your immune system
Seasonal SCIT works by gradually introducing escalating doses of the specific pollen extracts to which a patient is IgE-sensitized, shifting immune responses from the allergic Th2 pathway toward regulatory T-cell (Treg) mediated tolerance. Allergen-specific IgG4 blocking antibodies rise 10- to 100-fold during the first 1–3 months, competing with IgE at allergen-binding sites on mast cells and basophils. Over 3–5 years, tissue eosinophil and mast cell counts fall in nasal and bronchial mucosae, and Th2-driven cytokine production declines.
IgE-Guided Extract Selection
A board-certified allergist uses skin prick testing or serum-specific IgE results to identify which seasonal pollens are clinically relevant drivers — tree, grass, or weed — and assembles a custom extract vial weighted to the regional pollen calendar.
Build-Up: Dose Escalation
Weekly injections of progressively increasing extract concentrations (from 1:10,000 to 1:1,000 of maintenance concentration) desensitize mast cells and basophils while initiating Treg expansion. Each visit requires a 30-minute observation period per Cox 2011 PP3 — approximately 70% of systemic reactions begin within that window.
Maintenance: Immune Consolidation
At the effective maintenance dose — approximately 7–20 µg Amb a 1 for ragweed, ~7 µg Phl p 5 for timothy grass — injections continue every 2–4 weeks for 3–5 years. Allergen-specific IgG4 continues rising; IgE-mediated reactivity declines progressively.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
The seasonal allergy shot timeline follows the same three-phase structure as any SCIT regimen — build-up, maintenance, and discontinuation — and is not adjusted by the outdoor pollen calendar except in European pre-seasonal protocols uncommon in the US.
26–28 weekly injections escalate the extract dose from highly diluted to near-maintenance concentration. Cluster schedules (Tabar 2005: multiple injections per visit) reach maintenance in 7–13 visits. Rush build-up (1–3 days, Bernstein 2008) carries a higher systemic-reaction rate and requires intensive premedication. Each injection is followed by a mandatory 30-minute observation period (Cox 2011 PP3 Summary Statement 33).
Once at maintenance dose, visits drop to every 2–4 weeks for 3–5 years. Gaps greater than 3–4 months typically require restarting from a lower dose. The 30-minute post-injection observation remains mandatory at every maintenance visit. Only 43.9% of patients starting AIT reach maintenance per Tkacz 2021 MarketScan.
Durham 1999 NEJM documented at least 3 years of sustained clinical benefit after stopping a 3–4 year grass SCIT course. The pediatric PAT study (Jacobsen 2007) confirmed a halving of asthma incidence at 10-year follow-up. Disease modification persists because long-lived IgG4-producing plasma cells continue providing allergen-blocking antibodies post-treatment.
Efficacy by allergen — what the data shows
Seasonal allergic rhinitis is the indication with the deepest SCIT evidence base. The Cochrane systematic review by Calderón 2007 synthesized 51 RCTs across 2,871 patients and found clinically meaningful reductions in both symptom scores (SMD −0.73) and rescue medication use (SMD −0.57). Per-allergen landmark data confirm the magnitude for the most common seasonal triggers.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Seasonal AR patients have several management options: SCIT (now available as an at-home allergy shot, not only an in-clinic one), FDA-approved SLIT tablets, sublingual drops, pharmacotherapy, and depot corticosteroids. Understanding the differences is essential because a single IM steroid injection — still offered at some urgent-care and primary-care clinics — is categorically different from SCIT and professionally discouraged.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
At-home SCIT (Curex allergy shots) | |||||
SLIT tablets (Grastek/Oralair/Ragwitek) | |||||
SLIT drops (compounded, off-label) | |||||
Antihistamines + intranasal steroids | |||||
Depot corticosteroids (Kenalog-40 / Depo-Medrol) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients who don't want a 39-visit build-up year of in-clinic injections plus the travel and waiting room, Curex delivers the allergy shot itself at home for $129/month all-inclusive: a personalized SCIT serum sterile-compounded to USP <797> standards, prescribed and overseen by a board-certified allergist, with your first injection and every dose change supervised live over Zoom and a prescribed epinephrine auto-injector confirmed on hand. It is the same disease-modifying seasonal immunotherapy as clinic shots — the same pollen extracts, the same gradual build-up — with no HOPD facility fees.
See if at-home shots are right for youSide effects — what to watch for
Seasonal SCIT carries the same injection-site and systemic reaction profile as any SCIT regimen. Most reactions are local, mild, and manageable; systemic reactions are rare, and a 30-minute post-injection observation follows every dose — in the at-home setting your first injection and every dose change are supervised live over Zoom with a prescribed epinephrine auto-injector on hand, then you self-observe for that window.
Frequently asked questions
Is a seasonal allergy shot the same as getting a yearly Kenalog injection?
No — these are two completely different products. A seasonal allergy shot in the immunotherapy sense is subcutaneous immunotherapy (SCIT): a 3–5 year course of escalating allergen-extract injections that retrains the immune system. Kenalog-40 (triamcinolone acetonide) is a depot corticosteroid — a single intramuscular injection that suppresses allergic symptoms for one to three weeks per the FDA label. The AAAAI/ACAAI rhinitis Practice Parameter discourages single parenteral steroid administration for seasonal AR and contraindicates recurrent use because of hypothalamic-pituitary-adrenal axis suppression. SCIT is disease-modifying; Kenalog is purely symptomatic.
How many allergy shots do I need per season to see benefit?
Seasonal SCIT is not delivered on a per-season schedule — it is a continuous 3–5 year regimen regardless of pollen season. Year 1 requires approximately 39 injection visits (26–28 weekly build-up injections plus 13 early maintenance visits) per Cox 2011 PP3; maintenance thereafter averages 14 per year. Traditionally each was an in-clinic trip, but with Curex's at-home allergy shot those same weekly doses are self-administered at home — the first injection and every dose change supervised live over Zoom — so the schedule no longer means 39 clinic trips. Benefits typically become noticeable within the first pollen season after reaching maintenance dose, with the full disease-modifying effect accumulating over 3–5 years. Pre-seasonal-only SCIT (build-up before each pollen season) is more common in European practice and uncommon in the US.
Can I start seasonal allergy shots any time of year?
Yes — in US practice, SCIT initiation is not restricted to outside-of-pollen-season timing as it is in some European protocols. Cox 2011 PP3 does note that starting during peak pollen season increases the risk of systemic reactions because baseline immune activation is elevated, so many allergists prefer initiating build-up in the fall or winter for grass- or ragweed-allergic patients. However, a board-certified allergist can begin SCIT at any time of year, adjusting the build-up schedule and dose increments appropriately.
Do seasonal allergy shots prevent asthma?
Pediatric pollen SCIT has the strongest disease-prevention evidence in the immunotherapy literature. The PAT study (Möller 2002 JACI, Jacobsen 2007 Allergy) randomized 205 children with allergic rhinitis to SCIT or open control; at 10-year follow-up, 16/64 SCIT children had developed asthma versus 24/53 controls, yielding an adjusted OR of 4.6 (95% CI 1.5–13.7) favoring asthma-free status in the SCIT group. No pharmacotherapy has produced a comparable disease-prevention effect. Asthma-prevention benefit is NOT documented for SCIT started in adults.
What is the dropout rate for seasonal allergy shots?
Real-world adherence is substantially lower than clinical-trial completion rates. Tkacz 2021 (MarketScan, n=103,207 commercial AIT patients) found 23.9% never returned for their first injection after AIT initiation and only 43.9% reached the maintenance dose. The primary driver is visit burden: Year 1 has traditionally meant approximately 39 in-clinic trips, each with a 30-minute post-injection observation period. An at-home option directly targets that driver — Curex delivers the same weekly shot at home for eligible patients, with the first injection and every dose change supervised live over Zoom, removing the travel that drives most dropout; you should still plan your weekly dosing schedule before starting.
Are seasonal allergy shots effective for tree, grass, and ragweed at the same time?
Yes — SCIT vials are typically compounded as multi-allergen mixtures. A single vial can contain extracts for multiple seasonal pollens simultaneously: tree pollens (oak, birch, hickory), grass mix (timothy, orchard, Kentucky bluegrass), and short ragweed. The allergen selection is based on the patient's IgE-sensitization profile, not a generic combination. Some allergists separate incompatible allergens into different vials — for example, alternating grass-and-tree vials with a separate weed vial. The SCIT regimen for one allergen or a multi-allergen mix follows the same dosing schedule.
How long do the benefits of seasonal allergy shots last after finishing?
Durham 1999 NEJM documented grass SCIT delivering sustained clinical benefit for at least 3 years after stopping a 3–4 year course, with persistent immunologic changes including allergen-specific IgG4. Population-level data suggest benefit lasting 3–12 years after completing treatment. The pediatric PAT study (Jacobsen 2007) confirmed disease-prevention benefits at 10-year follow-up. Benefits are more durable in patients who complete the full course; partial courses (fewer than 3 years) are less likely to produce lasting remission.
What is the 30-minute wait after allergy shots for?
The 30-minute post-injection observation period is required after every SCIT dose under Cox 2011 PP3 (Summary Statement 33) and AAAAI/ACAAI position statements because approximately 70% of systemic allergic reactions occur within that window. The at-home SCIT model preserves that safeguard: your first injection and every dose change are supervised live over Zoom by the prescribing physician, and a prescribed epinephrine auto-injector is confirmed on hand before your first dose so anaphylaxis can be treated immediately while you call 911. Completing the full 30-minute self-observation after every dose matters — late systemic reactions are less predictable, so stay put and monitored for the window. If you experience throat tightness, difficulty breathing, generalized hives, or lightheadedness at any point, use your epinephrine auto-injector and call 911, then notify your care team.
Related Articles
Are There Seasonal Allergy Shots? Yes — 3 Types | Curex
Yes — seasonal allergy shots exist as SCIT, SLIT tablets, or depot steroid. Curex at-home SCIT ($129/mo) covers tree, grass, and weed pollen.
Read moreAllergy Shot for Seasonal Allergies — Single Shot? | Curex
One allergy shot won't treat seasonal allergies — SCIT requires 60–80 injections over 3–5 years. A single IM steroid shot exists but is discouraged. Learn the real options.
Read moreMold Allergy Shots: Evidence & Limits | Curex Guide
Mold SCIT has one well-controlled RCT allergen — Alternaria (Kuna 2011: 63.5% reduction). Cladosporium, Aspergillus, Stachybotrys lack RCT support. Full honest guide.
Read moreAllergy Shots vs Drops: Evidence-Based Comparison | Curex
Allergy shots (SCIT) vs sublingual drops (SLIT): comparable efficacy per Nelson 2015, but SLIT has zero fatalities vs 1 per 2.5M shots. Full comparison.
Read moreCat Allergy Shots for Humans | Curex SCIT Guide
Cat allergy shots use FDA-standardized Fel d 1 extract for ~72% symptom relief. RCT evidence, schedule, plus at-home SCIT from Curex at $129/mo.
Read moreTypes of Allergy Shots: Complete Matrix Guide | Curex
8 products called 'allergy shots' compared: SCIT, SLIT tablets, Xolair, Dupixent, Tezspire, depot steroids, epinephrine, and VIT. Only SCIT and SLIT modify allergen immunity.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.